Delineating an extracellular redox-sensitive module in T-type Ca2+ channels by Huang, D et al.
Delineating an extracellular redox-sensitive module in T-type
Ca2 channels
Received for publication, January 15, 2020, and in revised form, March 17, 2020 Published, Papers in Press, March 18, 2020, DOI 10.1074/jbc.RA120.012668
X Dongyang Huang‡§, Sai Shi¶, Ce Liang‡, Xiaoyu Zhang‡, Xiaona Du‡, Hailong An¶, Chris Peers**†,
X Hailin Zhang‡1, and X Nikita Gamper‡ ‡‡2
From the ‡Department of Pharmacology, Hebei Medical University, Shijiazhuang 050000, China, the §Institute of Chinese
Integrative Medicine, Hebei Medical University, Shijiazhuang 050000, China, the ¶State Key Laboratory of Reliability and
Intelligence of Electrical Equipment, Hebei University of Technology, Tianjin 300401, China, the Key Laboratory of Molecular
Biophysics, Hebei Province, Institute of Biophysics, School of Science, Hebei University of Technology, Tianjin 300401, China, the
**Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom, and the ‡‡Faculty of Biological Sciences,
University of Leeds, Leeds LS2 9JT, United Kingdom
Edited by Mike Shipston
T-type (Cav3) Ca2 channels are important regulators of
excitability and rhythmic activity of excitable cells. Among
other voltage-gated Ca2 channels, Cav3 channels are uniquely
sensitive to oxidation and zinc. Using recombinant protein
expression in HEK293 cells, patch clamp electrophysiology,
site-directed mutagenesis, and homology modeling, we report
here that modulation of Cav3.2 by redox agents and zinc is medi-
ated by a unique extracellular module containing a high-affinity
metal-binding site formed by the extracellular IS1–IS2 and IS3–
IS4 loops of domain I and a cluster of extracellular cysteines in
the IS1–IS2 loop. Patch clamp recording of recombinant Cav3.2
currents revealed that two cysteine-modifying agents, sodium
(2-sulfonatoethyl) methanethiosulfonate (MTSES) and N-ethyl-
maleimide, as well as a reactive oxygen species–producing neu-
ropeptide, substance P (SP), inhibit Cav3.2 current to similar
degrees and that this inhibition is reversed by a reducing agent
and a zinc chelator. Pre-application of MTSES prevented fur-
ther SP-mediated current inhibition. Substitution of the zinc-
binding residue His191 in Cav3.2 reduced the channel’s sensitiv-
ity to MTSES, and introduction of the corresponding histidine
into Cav3.1 sensitized it to MTSES. Removal of extracellular
cysteines from the IS1–IS2 loop of Cav3.2 reduced its sensitivity
to MTSES and SP. We hypothesize that oxidative modification
of IS1–IS2 loop cysteines induces allosteric changes in the zinc-
binding site of Cav3.2 so that it becomes sensitive to ambient
zinc.
T-type Ca2 channels (CACNA1G, CACNA1H, and
CACNA1I genes; Cav3.1, Cav3.2, and Cav3.3 channel  sub-
units, respectively) are a family of voltage-gated Ca2 channels
with very negative activation thresholds (less than 60 mV)
and fast inactivation kinetics (1, 2). The channels are widely
distributed in the central and peripheral nervous systems,
heart, and vasculature as well as in several types of nonexcitable
cells (3, 4). In the central nervous system, T-type channels are
highly expressed in dendrites of thalamic and hippocampal
neurons, where they amplify subthreshold postsynaptic poten-
tials and facilitate the spread of depolarization to the cell body
(5). A negative activation threshold and fast recovery from inac-
tivation make T-type Ca2 channels an important contributor
to pacemaker activity in the thalamic, corticothalamic, and
other rhythmically active neurons (6, 7). Thalamic T-type cur-
rents are enhanced in several rodent models of absence epi-
lepsy; correspondingly, several gain-of-function mutations
within CACNA1 genes are associated with human epilepsies,
whereas T-type channel blockers have been shown to suppress
seizures and are efficacious in treatment of absent seizures in
humans (for a review, see Refs. 4, 8).
In the peripheral nervous system, T-type Ca2 channels (and
Cav3.2 in particular) are abundant in small-diameter, capsai-
cin-sensitive (presumably nociceptive) dorsal root ganglion
neurons (9 –12), as well as in two distinct types of low-threshold
mechanoreceptors innervating skin hair follicles (13). The dis-
covery of a relatively high abundance of T-type Ca2 channels
in nociceptors led to establishment of the prominent role of
these channels in peripheral nociceptive transmission. Condi-
tional deletion of Cav3.2 (13) or down-regulation in dorsal root
ganglia using intrathecal injection of antisense oligonucleotides
produced anti-nociceptive effects in rodent pain models of neu-
ropathic and inflammatory pain (14, 15) and reduced the anal-
gesic efficacy of T-type channel blockers (11). Conversely, mul-
tiple reports found T-type Ca2 currents or Cav3.2 expression
to be increased in chronic pain conditions, such as diabetic
neuropathy (14, 16), peripheral nerve injury, or inflammation
(12, 17–19).
Given their clear role in epilepsy and pain, regulation of
T-type Ca2 channel activity receives intense scrutiny. T-type
Ca2 channels are regulated by multiple phosphorylation (20),
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glycosylation (21, 22), and ubiquitination (12) mechanisms. In
addition to these, the Cav3.2 T-type subunit possesses a unique
regulatory mode that is targeted by several endogenous regula-
tory pathways: sensitivity to oxidation and zinc. Thus, Cav3.2 is
uniquely sensitive to submicromolar concentrations of extra-
cellular zinc (11, 23–25). The zinc-sensitive module is located
extracellularly, involving interaction of the extracellular loops
linking the IS1–IS2 and IS3–IS4 transmembrane regions of
domain I (23). His191, which is absent in Cav3.1 and Cav3.3
subunits, is critical for the high sensitivity of Cav3.2 to zinc and
nickel (11, 23, 26). In addition, T-type Ca2 currents recorded
in native nociceptive neurons and recombinant Cav3.2 currents
are enhanced by reducing agents (DTT or L-cysteine) and
inhibited by the oxidizing agent 5,5-dithio-bis(2-nitrobenzoic
acid) and hydrogen peroxide (11, 27–30). Moreover, neuropep-
tide substance P, which induces generation of endogenous
reactive oxygen species (ROS)3 (31), inhibits endogenous
T-type Ca2 currents in primary somatosensory neurons and
recombinant Cav3.2 current via an oxidative mechanism (11).
Intriguingly, redox modulation of Cav3.2 also depends on
His191 (11, 24, 32). We have recently shown that oxidative mod-
ification of Cav3.2 channels (both recombinant and those
endogenously expressed in sensory neurons) induced by sub-
stance P enhances channel sensitivity to Zn2 to such an extent
that is becomes tonically inhibited by trace amounts of ambient
zinc (11). Cav3 channels contain a number of extra- and intra-
cellular cysteines that can be oxidized or reduced, depending on
the local redox environment, which, in turn, could affect the
conformation of the zinc-binding site. In this study, we com-
bined electrophysiology, site-directed mutagenesis, and com-
puter modeling to delineate the molecular determinants of the
unique redox sensitivity of Cav3.2.
Results
Cysteine-modifying reagents mimic the effect of redox
modulation of Cav3.2 by substance P
Neuropeptide substance P (SP) induces production of reac-
tive oxygen species in immune (33) and epithelial (34) cells and
sensory neurons (31). In the former cell type, SP inhibits T-type
Ca2 current via oxidative modification of Cav3.2 (11). A
mechanism of inhibition was proposed to be via enhancement
of Zn2 sensitivity of Cav3.2, whereby the oxidized channel is
inhibited by nanomolar free Zn2 present in the extracellular
milieu (11). However, it is presently unknown how oxidation of
Cav3.2 is translated into higher sensitivity to Zn2. Cav3 chan-
nels have multiple extra- and intracellular cysteines accessible
to redox modulation (Fig. 1A). To test whether cysteine modi-
fication is necessary for oxidative modulation of Cav3.2, we
performed patch clamp experiments testing the effects of the
cell-impermeable cysteine-modifying reagent sodium (2-sul-
fonatoethyl) methanethiosulfonate (MTSES; 2 mM) and the
cell-permeable cysteine-modifying reagent N-ethylmaleimide
(NEM; 200 M), on the recombinant Cav3.2 overexpressed in
HEK293 cells together with the SP receptor NK1 (Fig. 1, B–J).
MTSES (Fig. 1, B and C) and NEM (Fig. 1, D and E) inhibited the
Cav3.2 current to similar levels, and inhibition was also similar
in amplitude to that produced by the NK1-specific agonist
[Sar9]-substance P (S9SP; 1 M; Fig. 1, F–H). MTSES, NEM, and
SP inhibited peak Cav3.2 current amplitude by 40.1%  3.5%
(n  9, p  0.001), 36.1%  5.4% (n  7, p  0.001), and
40.1%  12.3% (n  6, p  0.05), respectively. The reducing
agent DTT (1 mM), applied in the presence of MTSES, NEM, or
SP (Fig. 1E), recovered most of the inhibitory action of the
agents, although, in the case of NEM, recovery was incomplete
(Fig. 1, F–H). Interestingly, when S9SP was applied after
MTSES, it produced no further inhibition, suggestive of a com-
mon mechanism of action for both agents (Fig. 1, I and J).
MTSES, NEM, or S9SP did not significantly affect the activa-
tion or inactivation kinetics of recombinant Cav3.2 (Table S1).
Ambient zinc and a high-affinity zinc-binding site are
necessary for Cav3 channel sensitivity to MTSES
It has been shown previously that Cav3.2 with the H191Q
mutation in the high-affinity zinc-binding site displayed much
lower sensitivity to SP (11). To examine whether His191 is
important for the effect of MTSES, we tested its effect on the
Cav3.2 (H191Q) mutant overexpressed in HEK293 cells
together with NK1 receptors (Fig. 2, A and D). MTSES had only
a modest inhibitory effect on Cav3.2 (H191Q) (23.1%  5.6%,
n  6, p  0.01); inhibition was significantly reduced compared
with WT Cav3.2 (Fig. 2D, p  0.05). Moreover, MTSES-in-
duced inhibition of Cav3.2 (H191Q) was no longer recoverable
with DTT (Fig. 2, A and D).
Cav3.1 subunit has glutamine instead of histidine in the posi-
tion equivalent to 191 in Cav3.2 (position 172 in Cav3.1) and,
hence, is much less sensitive to zinc (11, 23). Thus, we tested the
effect of MTSES on WT Cav3.1 and the Cav3.1 (Q172H)
mutant. MTSES produced only very modest inhibition of
9.3%  2.8% in WT Cav3.1 (n  5, p  0.05; Fig. 2, B and E).
Strikingly, the MTSES effect on Cav3.1 (Q172H) currents was
much stronger (inhibition of 36.9%  2.8%, n  6, p  0.001;
Fig. 2, C and E). MTSES inhibition of Cav3.1 (Q172H) was com-
parable with that of WT Cav3.2 (cf. Figs. 2, C and E, and 1, B and
C). The results further reinforce the hypothesis that oxidative
modulation of Cav3 channels depends on the high-affinity zinc-
binding site.
To further probe the requirement of zinc for the effect of
extracellular cysteine modification on Cav3 channel activity,
we applied the zinc chelator N,N,N, N-tetrakis(2-pyridylm-
ethy1) ethylenediamine (TPEN, 10 M) before or after MTSES.
The experiments presented in Fig. 3 demonstrate that TPEN
could totally recover the inhibition induced by MTSES on WT
Cav3.2; thus, 2 mM MTSES inhibited the peak Cav3.2 current to
61.2%  8.7% of baseline, and TPEN applied in the presence of
MTSES recovered the amplitude to 102.4%  5.5% of the base-
line (n  6; Fig. 3, A and C). Consistent with previous results,
MTSES inhibition of the Cav3.2 (H191Q) mutant was much
smaller (inhibition to 83.4%  1.7% of baseline, n  8; Fig. 3, B
and C), and this small inhibition was also recovered by TPEN
3 The abbreviations used are: ROS, reactive oxygen species; SP, substance P;
MTSES, sodium (2-sulfonatoethyl) methanethiosulfonate; NEM, N-ethyl-
maleimide; S9SP, [Sar9]-substance P; TPEN, N,N,N,N-tetrakis(2-pyridyl-
methy1) ethylenediamine; TRX, thioredoxin; cDNA, complementary DNA;
ANOVA, analysis of variance; Z944, N-[[1-[2-(tert-butylamino)-2-oxoethyl]-
piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide.
Redox-sensitive module of T-type Ca2 channels
6178 J. Biol. Chem. (2020) 295(18) 6177–6186









(Fig. 3, B and C). Application of TPEN on its own (Fig. 3, D–F)
did not significantly affect the amplitude of WT Cav3.2 or the
H191Q mutant (some run-up of the current amplitude was
observed in some recordings, but the effect did not reach sig-
nificance). Importantly, in the presence of TPEN, MTSES was
no longer able to inhibit currents produced by either of the
channels. Interestingly, under these conditions, we often
observed a small and very transient inhibition by MTSES (as
can be seen in the examples presented in Fig. 3, D and E) which
then spontaneously recovered. Clearly, binding of zinc to its
high-affinity extracellular binding site is necessary for the full
inhibitory action of MTSES. We also tested the effect of TPEN
on WT Cav3.1 and Cav3.1 (Q172H) mutant currents, and there
were no strong effects (Fig. 3, G–I). In WT Cav3.1, TPEN pro-
duced small inhibition, which is perhaps a nonspecific effect. In
the case of the Cav3.1 (Q172H) mutant, TPEN had no signifi-
cant effect (Fig. 3, H and I). Importantly, when applied in the
presence of TPEN, MTSES had no effect on WT Cav3.1 or the
Cav3.1 (Q172H) mutant (Fig. 3, G–I). This result was in stark
contrast to that shown in Fig. 2, C and E, where, in the absence
of TPEN, MTSES produced strong inhibition of the Cav3.1
(Q172H) mutant, which has its high-affinity zinc-binding
site reintroduced. Mutations H191Q (Cav3.2) and Q172H
(Cav3.1) did not significantly affect the activation and inac-
tivation kinetics and current densities of the respective
channels (Table S2).
Figure 1. Cysteine-modifying reagents and substance P inhibit recombinant Cav3.2 currents with a similar mechanism. A, schematic of the Cav3.2
channel; intra- and extracellular cysteines are indicated by spheres. Shown in red are cysteines mutated in this study. An orange square indicates zinc-binding
His191. The purple area indicates the high-affinity zinc-binding site. B, example time course of the effects of 2 mM MTSES and 1 mM DTT )applied in the presence
of MTSES) on the Ca2 current recorded from HEK293 cells transiently overexpressing Cav3.2 and NK1 receptors using a perforated patch clamp. The selective
T-type channel blocker Z944 (1 M) was applied at the end of the experiment. Plotted are peak Ca2 current amplitudes. Periods of drug application are
indicated by vertical gray bars. The inset shows example current traces. C, summary of the effects recorded in the experiments exemplified in B. Individual data
points are represented by colored circles. Paired data points from the same experiment are depicted in the same color. D, example time course of an experiment
similar to that shown in A, but NEM (200 M) was applied instead of MTSES. E, summary of the effects recorded in the experiments exemplified in D. F, example
time course of an experiment similar to that shown in B, but the selective NK1 receptor agonist S9SP (1 M) was applied instead of MTSES. G, summary of these
experiments. H, comparison of the Cav3.2 current inhibition produced by MTSES and S9SP. I, Example time course of the effects of 1 M S9SP applied after (and
in the presence of) MTSES on the recombinant Cav3.2 current. J, summary of these experiments. In bar/scatter charts, asterisks denote a significant difference
between the groups indicated by the line connectors. NS, not significant; *, p  0.05; ***, p  0.001 (paired t test or one-way ANOVA, as appropriate). Error bars
represent mean  S.E. The number of individual recordings is shown within the bars.
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In combination, the results presented in Figs. 1–3 point to
the following conclusions: cysteine-modifying agents and oxi-
dative modification have similar inhibitory effects on Cav3
channels; these effects require zinc and depend on the high-
affinity extracellular zinc-binding site formed by the extracel-
lular loops of domain I, and because MTSES is cell-imperme-
able, the cysteines mediating the redox inhibition must be
located in the extracellular regions of Cav3 channel proteins.
The cysteines in the IS1–IS2 extracellular loop of T-type Ca2
channels are necessary and sufficient for redox-mediated
inhibition of channel activity
Earlier studies defined critical residues of the high-affinity
metal-binding site of Cav3.2, including an Asp189-Gly190-His191
motif in IS3–S4 and an additional Asp residue in IS2 (23), with
His191 being a key residue absent in other Cav3 subunits (and
any other voltage-gated Ca2 channel  subunits). The high-
resolution cryo-EM structure of human Cav3.1 has been solved
recently (35). Because Cav3.1 is not highly sensitive to zinc or
redox-mediated modulation as a result of absence of the critical
histidine residue in its IS3–S4 loop, we obtained the Cav3.2
structure using homology modeling and analyzed the putative
metal-binding site (Fig. 4 and Fig. S1). The “local quality” esti-
mate of the model (Fig. 4A) shows that the scores of all regions
except for a few loop regions are higher than 0.6, which indi-
cates that the overall structure of the model is reliable (Fig. 1A).
The putative metal binding site formed by extracellular IS1–
IS2 and IS3–IS4 regions is depicted in Fig. 1, B–E. The electro-
static surface potential of the Cav3.2 model indicates that the
lower potential in the extracellular region comprised of the
IS1–IS2 and IS3–IS4 loops is favorable for metal binding (Fig.
1E). Moreover, the model suggests that the electrostatic surface
potential near Glu127 and Glu137 is very low, and we suspect that
Glu127 and Glu137 may also contribute to metal binding. Inter-
estingly, four cysteines are located within or near this extracel-
lular region: Cys114, Cys123, Cys128, and Cys133 (Fig. 4, B–D).
Although side chains of several amino acids (e.g. methionines,
arginines, and aromatic amino acids) can be modified by oxi-
dizers, sulfhydryl groups of cysteines are by far the most sus-
ceptible to oxidation protein moieties (36). Cys123, Cys128, and
Cys133 have been suggested to be important for modulation of
T-type channels by lipoic acid (37) and nitric oxide (38). Thus,
we hypothesized that oxidative modification of some or all of
these residues may introduce allosteric changes to the metal-
binding site, favoring channel inhibition. To test this hypothe-
Figure 2. MTSES-induced inhibition of Cav3 channels requires an intact high-affinity zinc-binding site. A–C, example time courses showing the effects
of MTSES (2 mM), DTT (1 mM, applied in the presence of MTSES), and Z944 (1 M) on the Ca2 current recorded from HEK293 cells transiently overexpressing
Cav3.2 H191Q (A), WT Cav3.1 (B), or Cav3.1 Q172H (C). Plotted are peak Ca2 current amplitudes; periods of drug application are indicated by vertical gray bars.
The inset shows example current traces. D, summary of the effects recorded in the experiments exemplified in A. Individual data points are represented by
colored circles. Paired data points from the same experiment are depicted in the same color. Also shown is the dataset for MTSES-induced inhibition of the WT
Cav3.2 (gray bar, circles) taken from Fig. 1C. E, summary of the effects recorded in the experiments exemplified in B and C. In bar charts, asterisks denote a
significant difference between the groups indicated by the line connectors. *, p  0.05; **, p  0.01; ***, p  0.001 (paired or unpaired t test or one-way ANOVA,
as appropriate). Error bars represent mean  S.E. The number of individual recordings is shown within the bars.
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sis, we substituted these cysteines with alanines and tested the
sensitivity of the mutants to MTSES (Fig. 5). All single mutants
(C114A, C123A, C128A, and C133A) showed significantly
reduced sensitivity to MTSES (Fig. 5, A–D and F); C123A dis-
played the least sensitivity (Fig. 5, D and F). Importantly, the
quadruple mutant in which all of the abovementioned cysteines
were substituted with alanines was largely insensitive to
MTSES (Fig. 5, E and F). The quadruple mutant expressed very
poorly, with current density reduced more than 10-fold com-
pared with WT Cav3.2 (Table S2); hence, only four recordings
were produced.
We also tested the sensitivity of individual cysteine
mutants to SP (Fig. 6), and again, all four displayed much
reduced sensitivity with inhibition by 10 M S9SP in the
range of 10%–20% (compared with 45.1%  11.6%, n  7 in
the WT Cav3.2). We also tested one intracellular cysteine in
the intracellular IS2–IS3 linker, Cys165, as we reasoned it
could allosterically influence the arrangement of IS1–IS2
and IS3–IS4 loops. However, the C165A mutant still dis-
played obvious inhibition by SP (26.5%  3.9%, n  7), which
was not significantly different from SP-induced inhibition of
WT Cav3.2 (Fig. 6, A and B). None of the cysteine mutants
Figure 3. MTSES-induced inhibition of Cav3 channels is reversed by zinc chelation. A and B, example time courses showing the effects of MTSES (2 mM),
TPEN (10 M, applied in the presence of MTSES), and Z944 (1 M) on the Ca2 currents recorded from HEK293 cells transiently overexpressing WT Cav3.2 (A) or
Cav3.2 H191Q (B). C, summary of the effects recorded in experiments exemplified in A and B. Individual data points are represented by colored circles. Paired
data points from the same experiment are depicted in the same color. D and E, experiments similar to those shown in A and B, but MTSES was applied after (and
in the presence of) TPEN. F, summary of the effects recorded in the experiments exemplified in D and E. G and H, experiments similar to those shown in D and
E, but WT Cav3.1 (G) and Cav3.1 Q172H (H) were investigated. I, summary of the effects recorded in the experiments exemplified in G and H. In bar/scatter charts,
asterisks denote a significant difference between the groups indicated by the line connectors. NS, not significant; *, p  0.05; **, p  0.01; ***, p  0.001 (paired
or unpaired t test or one-way ANOVA, as appropriate). Error bars represent mean  S.E. The number of individual recordings is shown within the bars.
Redox-sensitive module of T-type Ca2 channels
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used in this study displayed significantly different activation
or inactivation kinetics. The current densities of single
mutants also did not change significantly compared with
WT Cav3.2. The only exception was the quadruple Cys-to-
Ala mutant, which displayed much reduced current density
(but the kinetics were not significantly affected; Table S2).
Taken together, the results presented in Figs. 4 – 6 strongly
suggest that oxidative modification of extracellular cysteines
in the IS1–IS2 loop increases sensitivity of Cav3.2 to inhibi-
tion by trace amounts of extracellular zinc by inducing con-
formational changes within the high-affinity metal-binding
site of the channel.
Discussion
Here we report that modulation of T-type Ca2 channels by
redox agents and zinc is structurally coupled and depends on
the presence of the high-affinity metal-binding site formed by
the extracellular IS1–IS2 and IS3–IS4 loops of domain I, as well
as on the group of extracellular cysteines present in the IS1–IS2
loop.
A mechanism for convergence of redox- and zinc-dependent
modulation of T-type Ca2 channels has been hypothesized in
earlier studies, where it was proposed that His191 could be sub-
ject to a metal-catalyzed oxidation reaction (28, 36). Thus,
Figure 4. Homology modeling of the redox/metal-regulatory module in Cav3.2. The initial structure of the human Cav3.2 channel was obtained by
homology modeling (see Fig. S1 for further details) based on the structure of human Cav3.1 (35). A, local quality estimate of the model obtained with
QMEANBrane. B–D, the redox/metal-regulatory module shown at various rotation points (the protein is shown as ribbons, and key amino acids are indicated).
E, electrostatic surface potential of the redox/metal-regulatory module (50 kT/e to 50 kT/e, in a vacuum).
Redox-sensitive module of T-type Ca2 channels
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binding of Zn2 or Zn2-independent metal-catalyzed oxida-
tion of His191 could result in similar inhibition of channel activ-
ity (24, 28, 39). However, the data presented here suggest an
alternative mechanism: oxidative modification of extracellular
cysteines in the IS1–IS2 loop may allosterically increase the
Cav3 channel inhibition induced by binding of zinc to His191.
The following observations are in favor of the above hypothesis.
The cysteine-modifying reagents MTSES and NEM as well as
SP produced similar degrees of Cav3.2 inhibition, which was
reversible with the reducing agent DTT (Fig. 1) or the zinc
chelator TPEN (Fig. 3); pre-application of MTSES rendered SP
ineffective to produce any further current inhibition (Fig. 1, I
and J). Removal of His191 from Cav3.2 dramatically reduced
inhibition of the channel by MTSES (Fig. 2) or SP (11). Intro-
duction of the corresponding histidine into Cav3.1 induced its
sensitivity to MTSES (Fig. 2) and SP (11). Removal of extracel-
lular cysteines from the IS1–IS2 loop of Cav3.2 dramatically
reduced the sensitivity of the channel to MTSES (Fig. 5) and SP
(Fig. 6); the mutant with the cysteine-less IS1–IS2 loop was
found to be resistant to MTSES (Fig. 5, E and F). Thus, we
hypothesize that oxidative modification of extracellular cys-
teines in the IS1–IS2 loop of Cav3.2 induces allosteric changes
in its zinc-binding site so that it becomes sensitive to ambient
zinc. This effect is unique to Cav3.2 because other Cav3 sub-
units lack a critical histidine at positions equivalent to 191 in
Cav3.2. Indeed, according to our earlier atomic absorption
spectroscopy measurements, total zinc levels in nominally
zinc-free laboratory solutions are in the range of 5–10 M (11).
Figure 5. Extracellular cysteines in the IS1–IS2 loop are necessary for MTSES-mediated inhibition of Cav3.2. A–E, example time courses showing the
effects of MTSES (2 mM) and Z944 (1 M) on the Ca2 current recorded from HEK293 cells transiently overexpressing Cav3.2 C114A (A), Cav3.2 C123A (B), Cav3.2
C128A (C), and Cav3.2 C133A (D) or a quadruple mutant with Cys-to-Ala mutations at positions 114, 123, 128, and 133 (4xC-A, E). F, summary of the effects
recorded in the experiments exemplified in A–E. Individual data points are represented by circles. Asterisks denote a significant difference between the groups
indicated by the line connectors. *, p  0.05; **, p  0.01; ***, p  0.001 (one-way ANOVA). Error bars represent mean  S.E. The number of individual recordings
is given below each bar.
Figure 6. Extracellular cysteines in the IS1–IS2 loop are necessary for
SP-mediated inhibition of Cav3.2. A, example time courses showing the
effects of S9SP (1 M), DTT (1 mM, applied in the presence of S9SP), and Z944
(1 M) on the Ca2 current recorded from HEK293 cells transiently overex-
pressing Cav3.2 C165A. B, summary of the effects recorded in experiments
exemplified in A for HEK293 cells overexpressing Cav3.2 C114A, Cav3.2
C123A, Cav3.2 C128A, Cav3.2 C133A, or Cav3.2 C165A. Individual data points
are represented by circles. Asterisks denote significant difference between the
groups indicated by the line connectors. *, p  0.05; ***, p  0.001 (one-way
ANOVA). Error bars represent mean  S.E. The number of individual record-
ings is given below each bar.
Redox-sensitive module of T-type Ca2 channels
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A similar or higher range of zinc concentrations has been
reported for human plasma (40). Concentrations of free Zn2
(both in vitro and in vivo) are likely to be much lower compared
with total zinc; our estimate suggested a low nanomolar range
(11). This would still be sufficient to have a significant effect on
channel activity because the high-affinity zinc-binding site in
Cav3.2 has a nanomolar zinc affinity (11).
Activation of NK1 receptors has been shown to generate
endogenous ROS production (31, 33, 41), which is a necessary
step in NK1-mediated modulation of Cav3.2 (11). However, it is
presently unclear how intracellularly generated ROS act upon
an extracellular site within the Cav3.2 protein. One intriguing
possibility is that, in response to endogenous ROS release, cells
could release some redox-active molecules, such as thioredoxin
(TRX). Indeed, TRX can be secreted (42). Moreover, it is known
to inhibit Cav3.2 channels by interfering with their extracellular
zinc-binding site (43). A mechanism of TRPC channel regula-
tion through breakdown of the extracellular disulfide bond by
secreted TRX has been reported (42), and it is tempting to
hypothesize that a related mechanism could be at play in the
case of NK1-mediated modulation of T-type Ca2 channels.
However, further investigation is required to decipher this
intriguing signaling cascade.
The exact structural consequences of oxidation of IS1–IS2
cysteines have yet to be elucidated. These cysteines may be
involved in disulfide bonds or oxidized to cysteine sulfinic (Cys-
SO2H) or sulfonic (Cys-SO3H) acids (44). The Cryo-EM struc-
ture of Cav3.1 revealed a disulfide bond between Cys104 in IS1–
IS2 and Cys889 on the IIS5–IIS6 pore loop, which is unique to
Cav3 channels (35). This bond was hypothesized to be impor-
tant for the unique redox sensitivity of T-type Ca2 channels
(35). Cys104 and Cys889 in Cav3.1 correspond to Cys123 and
Cys939 in Cav3.2 (Fig. 1A), and our model of Cav3.2 (Fig. 4 and
Fig. S1) also predicts a disulfide bond between these residues in
Cav3.2, whereas other cysteines in the IS1–IS2 loop do not form
disulfide bonds. Interestingly, the C123A Cav3.2 mutant was
the least sensitive to MTSES among all cysteine mutants we
tested (Fig. 5). Thus, perhaps this covalent bond, linking the
high-affinity zinc-binding site to the pore region of the channel,
is indeed important for coupling of zinc binding to channel
activity and it could be promoted by oxidation. However,
because other IS1–IS2 loop cysteines also affect channel sensi-
tivity to MTSES and SP, the Cys123-Cys939 bond is likely not an
exclusive determinant.
Oxidative modification of extracellular cysteines in the IS1–
IS2 loop may produce conformational changes within the high-
affinity zinc-binding site of the channel that either increases
zinc affinity at the binding site or enhances coupling efficiency
between zinc binding and channel inhibition. We believe that
the latter is more likely to be the case because SP treatment
strongly increased the efficacy of zinc-mediated inhibition of
Cav3.2 while having no effect on IC50 (11). Resolving Cav3.2
structures in the presence and absence of zinc and at different
states of extracellular cysteine oxidation will shed the light on
the exact mechanism of coupling between these two modula-
tory mechanisms. Nevertheless, this study clearly demonstrates
that the redox and zinc modulation of Cav3.2 is indeed struc-
turally coupled and requires the metal-coordinating histidine
in the IS3–IS4 loop and extracellular cysteines in the IS1–IS2
loop.
T-type Ca2 channels are important regulators of excitabil-
ity and rhythmic activity of excitable cells; the activity of these
channels is regulated by multiple physiological signaling path-
ways, many of which act on the channel targeting its redox/
zinc-sensitive module. Examples of these modulatory pathways
include nitrous oxide (38, 45), carbon monoxide and thiore-
doxin (43), hydrogen sulfide (46), -lipoic acid (37), as well as
GABAB receptors (47) and substance P (11). Hence, elucidation
of structural background of T-type channel modulation via the
redox/zinc-sensitive module reported here sheds new light on
the physiological regulation of these channels; moreover, it pro-
vides valuable insights into the development of future T-type
channel modulators for treatment of excitability disorders,
such as epilepsy and pain.
Experimental procedures
Cell culture, transfections, cDNA constructs, and chemicals
HEK293 cells were cultured in DMEM supplemented with
GlutaMax I, 10% fetal calf serum, penicillin (50 units/ml), and
streptomycin (50 g/ml) in culture flasks in a humidified incu-
bator (37 °C, 5% CO2). Cultures were passaged every 2 days
(upon reaching 80%–90% confluency); 1 day before transfec-
tion, the cells were passaged on glass coverslips (1.3  1.3 cm).
All cell culture reagents were purchased from Gibco-BRL
unless otherwise stated. Human NK1 receptor (GenBank
accession number AY462098) cDNA was purchased from the
Missouri Science and Technology cDNA Resource Center.
Cav3.1 (GenBank accession number AF027984), Cav3.2 (Gen-
Bank accession number AF051946), Cav3.1Q172H, and
Cav3.2H191Q were kindly provided by Dr. E. Perez-Reyes
(University of Virginia). Cav3.2 C114A, Cav3.2 C123A, Cav3.2
C128A, Cav3.2 C133A, Cav3.2 C165A, and Cav3.2 (C114A,
C123A, C128A, and C133A) were custom-made by Sangon Bio-
tech. HEK293 cells were transfected using FuGENE HD (Pro-
mega) according to the manufacturer’s instructions. MTSES
and Z944 were from Toronto Research Chemicals. All other
chemicals were from Sigma.
Electrophysiology
Amphotericin B perforated patch clamp recordings were
used to record Ca2 currents from transfected HEK293 cells.
Recordings were made using a Multiclamp 700B amplifier in
combination with pCLAMP 10.4 software (Axon Instruments,
Union City, CA) as described previously (11). Offline analysis
was performed using Clampfit 10.4 (Molecular Devices). Volt-
age clamp recordings were sampled at 4 kHz and performed
using the Amphotericin B perforated patch clamp method. The
standard bath solution contained 150 mM tetraethylammoni-
um-Cl, 2.5 mM CsCl, 2.5 mM CaCl2, 10 mM HEPES, 0.5 mM
MgCl2, and 10 mM glucose (pH 7.4 adjusted with CsOH, 305–
310 mosmol/kg). The solutions were applied to the bath cham-
ber using the eight-channel gravity perfusion system VC3– 8
(ALA Scientific Instruments) in combination with the local
perfusion pencil (04-08-250, AutoMate Scientific; inner diam-
eter, 250 m) at 	1 ml/min. The pipette solution contained
155 mM CsCl, 10 mM HEPES, 1 mM EGTA, and 4 mM MgCl2
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supplemented with amphotericin B (250 g/ml), pH 7.4-ad-
justed with CsOH. Patch electrodes were pulled with a horizon-
tal micropipette puller (P-97, Sutter Instruments) and fire-pol-
ished. The access resistance was typically within 6 –10
megaohm. Cav3 currents were measured by 50-ms square volt-
age pulses to 40 mV from a holding potential of 90 mV.
Series resistance was compensated online by 50%– 80%. All
recordings were performed at room temperature (	22 °C).
Homology modeling
The structural model of the Cav3.2 channel was constructed
using the homology modeling server SWISSMODEL (48) and
the Cav3.1 channel structure (PDB code 6KZO) (35) as a tem-
plate. The sequence identity of transmembrane regions of
CaV3.1 and CaV3.2 reached 84.27%. The resolution of the
Cav3.1 cryo-EM structure is 3.3 Å. The overall root mean
square deviation value of atomic positions between the Cav3.2
model and Cav3.1 cryo-EM structure is 0.26 Å (Fig. 1S).
QMEANBrane was used for reliable local quality estimation
of membrane protein models (49). For evaluation of the
overall protein structure, the validation server (SAVES v5.0,
Institute of Molecular Biology, University of California;
RRID: SCR_018219) was used. All molecular visualization
and structural diagrams were made using Open-Source
PyMOL (RRID:SCR_000305).
Statistics
All mean data are given as mean  S.E. Differences between
groups were assessed by Student’s t test (paired or unpaired, as
appropriate) or one-way ANOVA with Dunnett’s post hoc test.
The differences were considered significant at p  0.05. Statis-
tical analyses were performed using Origin 8.6 (OriginLab
Corp., Northampton, CA).
Data availability
All data are available in the main text or the supporting
information.
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